Dr. Marcus Williams, MD
NPI: 1730177155
Total Payments
$3,381
2024 Payments
$47.59
Companies
34
Transactions
178
Medicare Patients
880
Medicare Billing
$314,204
Payment Breakdown by Category
Food & Beverage$3,381 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,381 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $382.78 | 14 | $0 (2022) |
| AtriCure, Inc. | $360.20 | 11 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $348.81 | 24 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $327.77 | 25 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $285.64 | 21 | $0 (2023) |
| Amgen Inc. | $252.50 | 18 | $0 (2022) |
| Baxter Healthcare | $234.81 | 4 | $0 (2022) |
| ABIOMED | $217.97 | 4 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $103.02 | 7 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $98.84 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.59 | 2 | Daiichi Sankyo Inc. ($24.50) |
| 2023 | $396.47 | 25 | Novartis Pharmaceuticals Corporation ($218.82) |
| 2022 | $393.72 | 17 | AtriCure, Inc. ($169.62) |
| 2021 | $452.48 | 15 | ABIOMED ($203.15) |
| 2020 | $67.50 | 3 | Edwards Lifesciences Corporation ($53.03) |
| 2019 | $609.62 | 35 | Edwards Lifesciences Corporation ($237.65) |
| 2018 | $655.80 | 35 | BAXTER HEALTHCARE ($190.71) |
| 2017 | $757.64 | 46 | AstraZeneca Pharmaceuticals LP ($169.90) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/08/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Not Applicable | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $48.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/31/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/29/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology | ||||||
| 06/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: DIABETES | ||||||
| 04/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/23/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/23/2023 | LivaNova USA, Inc. | LIFESPARC (Device) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 150 | 152 | $160,562 | $52,556 |
| 2022 | 8 | 199 | 230 | $211,265 | $75,442 |
| 2021 | 8 | 214 | 232 | $229,337 | $73,854 |
| 2020 | 11 | 317 | 345 | $334,472 | $112,352 |
Total Patients
880
Total Services
959
Medicare Billing
$314,204
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33533 | Coronary artery bypass using artery graft, 1 graft | Facility | 2023 | 33 | 33 | $120,546 | $39,354 | 32.6% |
| 33518 | Coronary artery bypass using vein or artery graft, 2 grafts | Facility | 2023 | 15 | 15 | $11,999 | $4,156 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $10,736 | $3,611 | 33.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $6,670 | $2,017 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 22 | $6,061 | $1,971 | 32.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,494 | $1,079 | 30.9% |
| 33508 | Harvest of vein using an endoscope | Facility | 2023 | 32 | 32 | $1,056 | $368.32 | 34.9% |
| 33533 | Coronary artery bypass using artery graft, 1 graft | Facility | 2022 | 42 | 42 | $150,181 | $53,498 | 35.6% |
| 33519 | Coronary artery bypass using vein or artery graft, 3 grafts | Facility | 2022 | 14 | 14 | $15,132 | $5,609 | 37.1% |
| 33518 | Coronary artery bypass using vein or artery graft, 2 grafts | Facility | 2022 | 18 | 18 | $14,016 | $5,187 | 37.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $10,676 | $3,909 | 36.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $8,580 | $3,077 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 31 | $8,294 | $2,548 | 30.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 38 | $3,048 | $1,111 | 36.5% |
| 33508 | Harvest of vein using an endoscope | Facility | 2022 | 42 | 42 | $1,338 | $502.44 | 37.6% |
| 33533 | Heart artery bypass, single graft | Facility | 2021 | 44 | 44 | $171,716 | $53,155 | 31.0% |
| 33518 | Combined vein and artery heart artery bypass, 2 grafts | Facility | 2021 | 27 | 27 | $23,337 | $8,316 | 35.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 25 | 25 | $11,303 | $4,253 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 33 | $8,013 | $2,888 | 36.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $7,772 | $2,773 | 35.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,406 | $1,120 | 32.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 27 | $2,232 | $800.01 | 35.8% |
| 33508 | Harvest of veins for coronary artery bypass procedure using an endoscope | Facility | 2021 | 46 | 46 | $1,558 | $548.32 | 35.2% |
| 33533 | Heart artery bypass to repair one artery | Facility | 2020 | 57 | 57 | $227,487 | $74,941 | 32.9% |
| 33519 | Combined multiple vein and artery heart artery bypasses | Facility | 2020 | 26 | 26 | $30,290 | $10,603 | 35.0% |
About Dr. Marcus Williams, MD
Dr. Marcus Williams, MD is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730177155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Williams, MD has received a total of $3,381 in payments from pharmaceutical and medical device companies, with $47.59 received in 2024. These payments were reported across 178 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,381).
As a Medicare-enrolled provider, Williams has provided services to 880 Medicare beneficiaries, totaling 959 services with total Medicare billing of $314,204. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Thoracic Surgery (Cardiothoracic Vascular Surgery)
- Location Bristol, TN
- Active Since 10/10/2005
- Last Updated 12/04/2014
- Taxonomy Code 208G00000X
- Entity Type Individual
- NPI Number 1730177155
Products in Payments
- ENTRESTO (Drug) $330.18
- BRILINTA (Drug) $321.87
- INSPIRIS RESILIA aortic valve (Device) $293.61
- LifeVest (Device) $285.64
- Corlanor (Drug) $237.26
- Impella (Device) $217.97
- COBRA FUSION 150 (Device) $144.59
- COSEAL (Device) $108.13
- XARELTO (Drug) $103.02
- FLOSEAL (Biological) $82.58
- PRALUENT (Drug) $82.33
- ELIQUIS (Drug) $74.80
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) $68.71
- ANGIOVAC (Device) $59.10
- INJECTAFER (Drug) $53.01
- SYNERGY ABLATION SYSTEM (Device) $52.73
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM (Device) $48.18
- INSPIRIS RESILIA AORTIC VALVE (Device) $47.20
- Trifecta GT Tissue Heart Valve (Device) $44.37
- ZIO Patch (Device) $41.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.